Know Cancer

or
forgot password

Pilot Study for Analysis of Tumor Gene Expression by DNA Microarray Analysis in Patients Undergoing Breast Cancer Surgery or Core Biopsy Sampling


Phase 1
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Pilot Study for Analysis of Tumor Gene Expression by DNA Microarray Analysis in Patients Undergoing Breast Cancer Surgery or Core Biopsy Sampling


OBJECTIVES:

- Assess tumor gene expression information from women undergoing surgery for breast
cancer or core biopsy sampling of the breast.

OUTLINE: This is a pilot study.

Tumor tissue is collected and analyzed for tumor gene expression by DNA microarray analysis
for research studies.

PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Undergoing surgery for breast cancer OR core biopsy sampling of the breast

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Tumor gene expression as assessed by DNA microarray analysis

Outcome Description:

tumor sample will be assessed by DNA microarray

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Claudine Isaacs, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Lombardi Cancer Research Center

Authority:

United States: Food and Drug Administration

Study ID:

CDR0000377341

NCT ID:

NCT00898937

Start Date:

September 1999

Completion Date:

December 2014

Related Keywords:

  • Breast Cancer
  • breast cancer
  • Breast Neoplasms

Name

Location

Lombardi Comprehensive Cancer Center at Georgetown University Medical CenterWashington, District of Columbia  20007